Recent News

Share
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
541 News Items found
Omar Abdel-Wahab and Salima Benbarche
MSK’s Omar Abdel-Wahab Honored for Research Targeting Blood Cancers

MSK physician-scientist Dr. Omar Abdel-Wahab, is being honored at the 2023 American Society of Hematology (ASH) Annual Meeting with the William Dameshek Prize, which recognizes individuals who have made outstanding contributions to the field of hematology.
MSK Awards & Appointments January 2023
MSK Awards & Appointments November 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
scientific image of mouse lung cancer cells
Lung Cancer Cells’ ‘Memories’ Suggest New Strategy For Improving Treatment

Research from the lab of cancer biologist Tuomas Tammela shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.
Ming Li
How One Lab at MSK Is Working To Harness the Power of the Immune System Against Cancer

Study by study, Dr. Ming Li's lab at MSK is sharing new insights into the molecular and cellular mechanisms involved in immune regulation.
Dr. Michel Sadelain, Director of the Center for Cell Engineering, Sloan Kettering Institute.
Disrupting a Single Gene Could Improve CAR T Cell Immunotherapy, New Study Shows

Learn how disrupting a gene called SUV39H1 could make CAR T cells more powerful.
MSK Awards & Appointments January 2023
MSK Awards & Appointments October 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023

New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Article
A research working in an MSK lab
MSK Research Highlights, October 19, 2023

New MSK research examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress response in response to genomic instability in mitochondrial DNA.
Researchers Russell Kunes, Thomas Walle, and Dana Pe'er
MSK Researchers Develop New Open-Source Method To Improve Decoding of Single-Cell Data

MSK researchers have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data — and made it freely available to researchers around the world.
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.